BPA
NUVB icon

Beacon Pointe Advisors’s Nuvation Bio NUVB Stock Holding History

Beacon Pointe Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Sell
632,251
-11,483
-2% -$56.1K 0.02% 590
2026
Q1 		$2.76M Buy
643,734
+384,522
+148% +$2.14M 0.01% 639
2025
Q4 		$2.32M Buy
259,212
+97,612
+60% +$605K 0.02% 562
2025
Q3 		$598K Sell
161,600
-50,350
-24% -$137K 0.01% 947
2025
Q2 		$413K Buy
211,950
+84,900
+67% +$177K ﹤0.01% 942
2025
Q1 		$224K Buy
127,050
+73,500
+137% +$167K ﹤0.01% 1119
2024
Q4 		$142K Buy
+53,550
New +$138K ﹤0.01% 1167
2024
Q2 		– Sell
-21,700
Closed -$79K – 1352
2024
Q1 		$79K Hold
21,700
– – ﹤0.01% 1317
2023
Q4 		$32.8K Buy
+21,700
New +$27.9K ﹤0.01% 1303

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Beacon Pointe Advisors's NUVB Position: Q2 2026 in Review

Beacon Pointe Advisors reduced its Nuvation Bio (NUVB) stake by 1.8% in Q2 2026, selling an estimated $56.1K and leaving 632,251 shares worth $3.59M. The position accounts for 0.02% of the portfolio, ranked #590.

Beacon Pointe Advisors first reported a position in NUVB in Q4 2023 and has held it in 9 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Beacon Pointe Advisors held 632,251 shares of Nuvation Bio worth $3.59M as of Q2 2026.
  • Beacon Pointe Advisors sold 11,483 Nuvation Bio shares in Q2 2026, an estimated $56.1K.
  • Nuvation Bio made up 0.02% of Beacon Pointe Advisors's portfolio in Q2 2026, its #590 holding.
  • Beacon Pointe Advisors first reported a position in Nuvation Bio in Q4 2023 and has held it in 9 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.